Study Ref. | Topic - Genes/TFs/Signaling Pathways | Categorization of Studies (Study involving) | Relevance to this study |
---|---|---|---|
[1] | Molecular Basis of Cardiac Myxomas | Histopathology, Clinical Details | Focuses on cardiac myxoma (CM), the most prevalent benign cardiac tumors. |
[2] | Cardiac Organoids | Human Samples | Addresses the limited regenerative capacity of the adult human heart, a key consideration in cardiac diseases. |
[3] | Cardiac Regeneration | Histopathology | Explores cardiac regeneration, which is directly related to the study’s focus on the limited regenerative potential of cardiomyocytes in cardiac myxoma (CM) development |
[4] | Cardiomyogenesis | Histopathology | Examines cardiomyogenesis, providing insights into the differentiation processes of cardiomyocytes that are crucial for understanding cardiac myxoma (CM) development. |
[5] | Cardiac regeneration and repair | Histopathology | Investigates cardiac regeneration and repair, which is relevant to the study as it delves into the regenerative potential of cardiac cells, a key aspect in understanding cardiac myxoma (CM) and its implications for cardiomyocyte biology. |
[6] | Cardiomyocyte cell-cycle arrest | Histopathology | Explores cardiomyocyte cell-cycle arrest, a critical concept to grasp the limited regenerative potential of cardiomyocytes |
[19] | Primary Cardiac Tumors | Clinical Details | Provides insights into primary cardiac tumors, which is relevant to understanding the rarity of benign cardiac myxoma (CM) and their unique features. |
[7] | Heart regeneration | Histopathology | Discusses the challenges related to heart regeneration and the limited regenerative capacity of cardiomyocytes, which is crucial for understanding the significance of cardiac myxoma (CM). |
[8] | Cardiac Stem Cells | Histopathology | Explores the relevance of cardiac stem cells, which play a role in understanding cardiac regeneration and potential connections to the cardiac myxoma (CM) development |
[9] | Cardiac transcription factors | Histopathology | Investigates cardiac transcription factors, shedding light on how they may influence cardiomyocyte biology and their resistance to neoplastic transformations, possibly contributing to the benign nature of cardiac myxoma (CM) |
[16] | Cardiac transcription factors | Human Samples | Investigates the implications of cardiac transcription factors, shedding light on cardiac myxoma (CM) development and its relationship with cardiomyocyte biology |
[10] | Cardiac Development and Remodeling | Histopathology | Explores cardiac development and remodeling, potentially offering insights into cardiac myxoma (CM) development and its implications for cardiac regeneration |
[17] | Cardiac Organoids | Human Samples | Investigates cardiac organoids, providing valuable information on cardiac biology, which can aid in understanding cardiac myxoma (CM) development and its relevance to cardiac regeneration. |
[18] | Cardiac Organoids | Human Samples | This provides valuable insights in unlocking the nature of cardiomyocytes |
[11] | Cardiac Organoids | Human Samples | This provides valuable insights in unlocking the nature of cardiomyocytes |
[12] | Cardiac Organoids | Human Samples | This provides valuable insights in unlocking the nature of cardiomyocytes |
[13] | Cardiac stem cells | Human Samples | Focuses on cardiac stem cells, which are of interest due to their potential role in understanding cardiac myxoma (CM) and cardiac regeneration. |
[14] | Cardiac Tumors | Clinical Details | Addresses the topic of cardiac tumors, which is relevant for understanding the etiology and characteristics of cardiac myxoma (CM) |
[15] | Cardiac Tumors | Clinical Details | Explores cardiac tumorigenesis |
[20] | Heart Regeneration | Human Samples | Provides insights into heart regeneration, a relevant concept for studying the limited regenerative potential of cardiomyocytes. |
[21] | Cardiac Regeneration | Human Samples | Explores cardiac regenerative potential |
[22] | Cardiac Regenerative Pathways | Human Samples | Essential to investigate the nature of cardiomyocytes |
[23] | Cardiac Organoids | Human Samples | Provides step by step progression of the cardiac development |
[24] | Cardiac Organoids | Human Samples | Provides insights into the cardiac developmental processes |
[152] | Cardiac Reprogramming Factors | Histopathology | Addresses the genetic architecture involved in cardiac reprogramming |
[153] | Cardiogenesis | Human Samples | Provides valuable details about the process of cardiac development |
[154] | Cardiac Progenitors | Histopathology | Addresses the development of cardiomyocytes from cardiac progenitors |
[155] | Heart Field | Human Samples | Provides valuable details about early stages of cardiac development |
[156] | Heart Field | Histopathology | Provides valuable details about early stages of cardiac development |
[58] | Heart Field | Histopathology | Provides valuable details about early stages of cardiac development |
[157] | Cardiac Progenitor Cells | Human Samples | Addresses the development of cardiomyocytes from cardiac progenitors |
[158] | Regenerative Cardiology | Human Samples | Helps to explore the relationship between cardiac myxoma (CM) and the limited regenerative potential of cardiomyocytes |
[159] | Cardiac development and remodeling | Human Samples | Essential in understanding the mechanisms governing cardiac cell fate |
[30] | Cardiogenesis | Human Samples | Essential to analyze the intricate processes of cardiac development |
[25] | Islet1 - control of cardiomyocyte cell fate | Histopathology | Provides insights into Isl1 and its role in controlling cardiomyocyte cell fate, which is a key aspect of the study’s focus on cardiac myxomas and the transformation of cardiomyocytes into progenitor-like cells |
[26] | Islet1 - cardiac progenitor proliferation | Histopathology | Offers insights into Isl1 and its role in cardiac progenitor proliferation |
[27] | Islet1 - Cardiac Progenitor Cells | Human Samples | Focuses on Isl1 as one of the earliest expressed transcription factors in Cardiac Progenitor Cells |
[28] | Islet1 - Cardiomyogenesis | Histopathology | Discusses Isl1 and its role in cardiomyogenesis, contributing to the understanding of cardiac development |
[29] | Islet1 - Cardiac Development | Human Samples | Provides insights into Isl1 and its role in controlling cardiomyocyte cell fate |
[31] | Islet1 and Tbx5 interaction | Human Samples | Provides insights into how these interactions may influence cardiac programming |
[32] | Islet1 in Cardiac Progenitors | Human Samples | Points to the significance of Isl1 in cardiac progenitor cells |
[33] | Cardiac Stem Cells | Histopathology | Aligns with the study’s exploration of cardiac myxomas and their potential influence on the limited regenerative capacity of cardiomyocytes |
[34] | Islet1 – Cardiac Differentiation | Histopathology | Provides insights into the influence of Isl1 on the process of cardiac differentiation |
[35] | Islet1 – Cardiac Repair | Histopathology | Provides insights into the influence of Isl1 on the process of cardiac repair |
[36] | Islet1 and Nkx2–5 interaction | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[37] | Islet1 with Mef2c and GATA4 | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[38] | Islet1 with Nkx2–5 and GATA4 | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[39] | Islet1 - Cardiac Morphogenesis | Histopathology | Offers insights into the factors influencing cardiac genetic architecture |
[160] | Islet1 in Cancer Progression | Human Samples | Essential to understand the nature and impact of Isl1 in tumorigenesis |
[161] | Islet1 in different tumors | Human Samples | Essential to understand the nature and impact of Isl1 in tumorigenesis |
[162] | Islet1 in different tumors | Human Samples | Essential to understand the nature and impact of Isl1 in tumorigenesis |
[163] | Islet1 in tumorigenesis | Human Samples | Essential to understand the nature and impact of Isl1 in tumorigenesis |
[164] | Islet1 in different tumors | Histopathology | Essential to understand the nature and impact of Isl1 in tumorigenesis |
[40] | Multipotent cardiac stem cells | Human Samples | Essential to explore the aspects of cardiac regeneration and differentiation |
[41] | Nkx2–5 and Isl1 interaction | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[42] | Isl1 repression | Histopathology | Related to the study’s interest in the control of cardiomyocyte cell fate and differentiation. |
[43] | Islet-1 modulating estrogen receptor | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[44] | Islet-1 modulating estrogen receptor | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[45] | Islet1 and GATA4 interaction | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[46] | Brg1/Baf60 – Smarcd3 complex in Pluripotency and Differentiation | Histopathology | Relevant to understanding the molecular mechanisms related to cardiomyocyte reprogramming in cardiac myxoma (CM) |
[47] | Brg1/Baf60 – Smarcd3 complex in Cardiac Development | Human Samples | Provides insights into the regulatory pathways that may be involved in cardiac myxoma (CM) development |
[48] | Brg1/Baf60 – Smarcd3 complex in Development and Cancers | Human Samples | Potentially offering valuable information about how it may play role in the transformation of cardiomyocytes into progenitor-like cells in cardiac myxoma (CM) development |
[49] | Brg1/Baf60 – Smarcd3 complex in EMT transition | Human Samples | Essential to investigate the progenitor-like state in cardiac myxoma (CM) |
[50] | Brg1/Baf60 – Smarcd3 complex in EMT transition | Human Samples | Essential to investigate the progenitor-like state in cardiac myxoma (CM) |
[51] | Brg1/Baf60 – Smarcd3 complex and p53 interaction | Histopathology | Addresses how key genes are regulated in cardiac development |
[52] | Brg1/Baf60 – Smarcd3 complex in cardiomyocyte fate | Histopathology | Provides insights into the development of cardiogenic cell fate |
[53] | Brg1/Baf60 – Smarcd3 complex in cardiac progenitor cells | Histopathology | Relevant to understanding how these cells may influence the development of cardiac myxoma and the reversion of cardiomyocytes to a progenitor-like state |
[54] | Brg1/Baf60 – Smarcd3 complex in cardiogenesis | Histopathology | Provides insights into the regulatory pathways that may be involved in cardiac myxoma (CM) development |
[55] | Brg1/Baf60 – Smarcd3 complex: Tbx5 in cardiogenesis | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[165] | Brg1/Baf60 – Smarcd3 complex in development processes | Histopathology | Provides insights about the nature of this complex |
[166] | Brg1/Baf60 – Smarcd3 complex in tumorigenesis | Histopathology | Essential to understand the nature and impact of Baf60 in tumorigenesis |
[56] | Brg1/Baf60 – Smarcd3 complex’s interaction with Nkx2–5 | Human Samples | Provides insights about how these interactions may influence cardiac programming |
[57] | Brg1/Baf60 – Smarcd3 complex’s interaction with Nkx2–5 | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[58] | Nkx2–5 in heart field | Histopathology | Provide insights into the potential role of Nkx2–5 in cardiac myxoma development and its control over cardiac progenitor cells. |
[167] | Nkx2–5 in controlling proliferation | Histopathology | Relevant to elucidate Nkx2–5’s potential role in limiting tumorigenesis in cardiac myxomas by controlling the proliferation of cardiac progenitor cells |
[59] | Nkx2–5 and its interaction with wnt pathway | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[60] | Nkx2–5 and wnt in cardiogenesis | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[61] | Nkx2–5 as tumor suppressor | Histopathology | Provides insights into how Nkx2–5 exerts influence over the risk of cardiac tumorigenesis |
[62] | Nkx2–5 in cardiogenesis | Histopathology | Potentially shedding light on its influence in cardiac myxoma development |
[63] | Nkx2–5 and its interactions with Tbx1 in cardiogenesis | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[64] | Interaction of Nkx2–5 with tumor suppressor genes | Human Samples | Provides insights about how these interactions may influence cardiac programming |
[65] | Nkx2–5 in cardiac differentiation | Histopathology | Provides insights into how Nkx2–5 exerts influence over the risk of cardiac tumorigenesis |
[66] | Nkx2–5 and its interaction with BMP signaling | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[67] | Nkx2–5 and its interaction with FGF | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[68] | Nkx2–5 and its interactions with cardiac regulator genes | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[168] | Nkx2–5 in tumors | Human Samples | Essential to understand the nature and impact of Nkx2–5 in tumorigenesis |
[169] | Nkx2–5 in tumors | Human Samples | Essential to understand the nature and impact of Nkx2–5 in tumorigenesis |
[170] | Nkx2–5 and its interaction with tumor suppressor gene | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[171] | Nkx2–5 in tumors | Human Samples | Essential to understand the nature and impact of Nkx2–5 in tumorigenesis |
[172] | Nkx2–5 in tumors | Human Samples | Essential to understand the nature and impact of Nkx2–5 in tumorigenesis |
[173] | Nkx2–5 in tumors | Human Samples | Essential to understand the nature and impact of Nkx2–5 in tumorigenesis |
[174] | Nkx2–5 in tumors | Histopathology and Clinical Details | Essential to understand the nature and impact of Nkx2–5 in tumorigenesis |
[69] | Transcription factors in Cardiac Myxoma | Human Samples | Explores transcription factors in cardiac myxoma, which aligns with the focus of this study on cardiac myxoma and the role of transcription factors in its development |
[70] | Nkx2–5 in cardiogenesis | Histopathology | Potentially shedding light on its influence in cardiac myxoma development |
[71] | Nkx2–5 and Oct4: cardiac reprogramming | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[72] | Nkx2–5 and Oct4: cardiac reprogramming | Human Samples | Provides insights about how these interactions may influence cardiac programming |
[73] | GATA4 in cardiogenesis | Histopathology | Potentially shedding light on its influence in cardiac myxoma development |
[74] | GATA4 in cardiogenic potential | Histopathology | Potentially shedding light on its influence in cardiac myxoma development |
[75] | GATA4 and its interaction with cyclin D2 | Human Samples | Provides insights about how these interactions may influence cardiac programming |
[76] | GATA4 and Shh in cardiogenesis | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[77] | GATA4 as tumor suppressor | Human Samples | Essential to understand the benign nature of cardiac myxoma |
[78] | GATA4 as tumor suppressor | Human Samples | Essential to understand the benign nature of cardiac myxoma |
[79] | GATA4 as tumor suppressor | Human Samples | Essential to understand the benign nature of cardiac myxoma |
[175] | GATA4 in cardiac repair | Human Samples | To understand the scope of GATA4 in cardiac programming |
[176] | GATA4 in cardiac remodeling | Human Samples | To understand the scope of GATA4 in cardiac programming |
[177] | GATA4 in activating cardiac gene expression | Histopathology | To understand the scope of GATA4 in cardiac programming |
[178] | GATA4 and its tumor suppressor role | Histopathology | Essential to understand the benign nature of cardiac myxoma |
[179] | GATA4 in liver tumors | Human Samples | Essential to understand the nature and impact of GATA4 in tumorigenesis |
[180] | GATA4 in other tumors | Human Samples | Essential to understand the nature and impact of GATA4 in tumorigenesis |
[181] | GATA4 in other tumors | Human Samples | Essential to understand the nature and impact of GATA4 in tumorigenesis |
[182] | GATA4 and its interaction with Wnt pathway | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[80] | GATA4 in cardiac tumorigenesis | Clinical Details | Relevant to the study’s focus on understanding the origins and mechanisms underlying cardiac myxoma development. |
[81] | GATA4 in cardiac tumorigenesis | Histopathology | Relevant to the study’s focus on understanding the origins and mechanisms underlying cardiac myxoma development. |
[82] | Tbx5 in stem cells | Human Samples | Aligns with the study’s exploration of Tbx5 and other key cardiac genes/TFs in the context of cardiomyocyte biology and cardiac regeneration |
[83] | Tbx5 in stem cells | Human Samples | Aligns with the study’s exploration of Tbx5 and other key cardiac genes/TFs in the context of cardiomyocyte biology and cardiac regeneration |
[84] | Tbx5 in cardiogenesis | Histopathology | Aligns with the study’s exploration of Tbx5 and other key cardiac genes/TFs in the context of cardiomyocyte biology and cardiac regeneration |
[85] | Mutated Tbx5 | Histopathology | To understand the extent of Tbx5 role in governing cardiomyocytes |
[86] | Tbx5 in cardiac cell fate | Histopathology | Provides insights about the nature of cardiomyocytes |
[87] | Tbx5 and its interaction with mef2c | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[88] | Tbx5 and its role as tumor suppressor | Human Samples | Essential to understand the benign nature of cardiac myxoma |
[89] | Tbx5 and its dysregulations in cardiogenesis | Histopathology | To understand the extent of Tbx5 role in governing cardiomyocytes |
[90] | Mutated Tbx5 | Histopathology | To understand the extent of Tbx5 role in governing cardiomyocytes |
[91] | Mutated Tbx5 | Histopathology | To understand the extent of Tbx5 role in governing cardiomyocytes |
[92] | Tbx5 in cardiac differentiation | Histopathology | Provides insights about the limited regenerative capacity of cardiac cells and rare cardiac tumorigenesis |
[93] | Tbx5 in cardiac differentiation | Histopathology | Provides insights about the limited regenerative capacity of cardiac cells and rare cardiac tumorigenesis |
[94] | Tbx5 in promoting cardiac cell fate | Histopathology | Relevant to understand the role of Tbx5 in cardiac homeostasis |
[183] | Tbx5 in cardiac developmental defects | Histopathology | To understand the extent of Tbx5 role in governing cardiomyocytes |
[184] | Tbx5 in other tumors | Human Samples | Relevant to the study’s focus on understanding the origins and mechanisms underlying cardiac myxoma development. |
[185] | Tbx5 as tumor suppressor | Human Samples | Essential to understand the benign nature of cardiac myxoma |
[186] | Tbx5 in other tumors | Human Samples | Relevant to the study’s focus on understanding the origins and mechanisms underlying cardiac myxoma development. |
[95] | Tbx5 in inducing cardiac cell fate | Human Samples | Provides insights about the nature of cardiomyocytes |
[96] | Tbx5 in cardiac development | Histopathology | Provides insights about the nature of cardiomyocytes |
[97] | Mef2c in cardiogenesis | Histopathology | Relevant to understand the proliferative cardiac signaling |
[98] | Mef2c in myocardium | Histopathology | Related to interactions with proliferative genes |
[99] | Mef2c and its interaction with Nkx2–5 | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[100] | Mef2c in cardiac development | Histopathology | Potentially shedding light on its influence in cardiac myxoma development |
[101] | Mef2c and its interaction with Nkx2–5 | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[187] | Mef2c in other tumors | Clinical Details | Relevant to the study’s focus on understanding the origins and mechanisms underlying cardiac myxoma development. |
[188] | Mef2c in other tumors | Histopathology | Relevant to the study’s focus on understanding the origins and mechanisms underlying cardiac myxoma development. |
[189] | Mef2c and its interactions with stemness regulators | Histopathology | Provides insights about progenitor-like state in cardiac myxoma |
[190] | Mef2c in other tumors | Histopathology | Essential to understand the its nature and impact on tumorigenesis |
[191] | Mef2b in other tumors | Human Samples | Essential to understand the its nature and impact on tumorigenesis |
[192] | Mef2b in other tumors | Human Samples | Essential to understand the its nature and impact on tumorigenesis |
[102] | Mef2c in cardiac tumorigenesis | Histopathology | Essential to understand the its nature and impact on tumorigenesis |
[103] | Mef2c in cardiogenesis | Histopathology | Relevant to cardiac genetic programming |
[104] | Mef2c in cardiogenesis | Histopathology | Relevant to cardiac genetic programming |
[105] | Mef2c and its interaction with Tbx1 | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[106] | HAND1/2 in cardiac differentiation | Human Samples | Provides insights about the limited regenerative capacity of cardiac cells and rare cardiac tumorigenesis |
[107] | HAND1/2 in cardiogenesis and in heart defects | Histopathology | Relevant to understand its impact on cardiac programing and in different stages of cardiac development |
[108] | HAND1/2 in cardiac regeneration | Histopathology | Relevant to understand its impact on cardiac programing and on the limited cardiac regenerative potential |
[109] | HAND1/2 in cardiac regeneration | Histopathology | Relevant to understand its impact on cardiac programing and on the limited cardiac regenerative potential |
[193] | HAND1/2 in other tumors | Histopathology | Essential to understand the its nature and impact on tumorigenesis |
[194] | HAND1/2 as tumor suppressor | Human Samples | Provides insights about rare occurrence of cardiac tumors |
[195] | HAND1/2 as tumor suppressor | Histopathology | Provides insights about rare occurrence of cardiac tumors |
[196] | HAND1/2 as tumor suppressor | Human Samples | Provides insights about rare occurrence of cardiac tumors |
[110] | HAND1/2: Cardiac myxoma showing progenitor-like state | Human Samples | Relevant to understand how HAND1/2 govern the cardiac fate and prevent cardiomyocytes from reverting to progenitor-like state, hallmark of cardiac myxoma |
[111] | MYOCD - Cardiogenesis | Histopathology | Aligns with the study’s objective of understanding how MYOCD influences cardiomyocyte biology |
[112] | MYOCD in different cell types including cardiomyocytes | Human Samples | Provides insights about different roles it plays in different microenvironments |
[113] | MYOCD in stem cells | Histopathology | Provides insights about its influence on the stem cells, to understand the development of progenitor-like state in cardiac myxoma |
[197] | MYOCD in cardiac cell fate | Human Samples | Relevant to understand how this gene influences the combinatorial code of cardiomyocytes |
[198] | MYOCD in other tumors | Human Samples | Essential to understand the its nature and impact on tumorigenesis |
[199] | MYOCD as tumor suppressor | Histopathology | Provides insights about rare occurrence of cardiac tumors |
[200] | MYOCD and its interactions | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[201] | MYOCD in different tumors | Histopathology | Essential to understand the its nature and impact on tumorigenesis |
[202] | MYOCD in different tumors | Histopathology | Essential to understand the its nature and impact on tumorigenesis |
[203] | MYOCD and its interactions in promoting cardiogenic potential | Human Samples | Provides insights about how these interactions may influence cardiac programming |
[114] | MSX2 and its role in stemness | Histopathology | Provides insights about its influence on the stem cells, to understand the development of progenitor-like state in cardiac myxoma |
[115] | MSX2 in cardiac development | Histopathology | Relevant to understand how this gene influences the combinatorial code of cardiomyocytes |
[116] | MSX2 and its role in stemness | Human Samples | Provides insights about its influence on the stem cells, to understand the development of progenitor-like state in cardiac myxoma |
[204] | MSX2 in promoting stemness | Human Samples | Provides insights about its influence on the stem cells, to understand the development of progenitor-like state in cardiac myxoma |
[205] | MSX2 in tumorigenesis | Histopathology | Essential to understand the its nature and impact on tumorigenesis |
[206] | MSX2 in other tumors | Histopathology | Essential to understand the its nature and impact on tumorigenesis |
[207] | MSX2 in cardiac diseases | Histopathology | Relevant to understand how this gene influences the combinatorial code of cardiomyocytes in diseased states |
[208] | MSX2 in other tumors | Human Samples | Essential to understand the its nature and impact on tumorigenesis |
[209] | MSX2 and its interaction with other stemness genes | Human Samples | Provides insights about how these interactions may influence cardiac programming |
[210] | MSX genes and their impact on apoptosis | Histopathology | Provides insights about rare occurrence of cardiac tumors |
[117] | HOPX and its interaction with Wnt and BMPs | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[118] | HOPX and its interaction with Nkx2–5 | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[119] | HOPX in cardiac differentiation | Histopathology | Provides insights about the limited regenerative capacity of cardiac cells and rare cardiac tumorigenesis |
[211] | HOPX in other tumors | Human Samples | Essential to understand the its nature and impact on tumorigenesis |
[212] | HOPX in other tumors | Histopathology | Essential to understand the its nature and impact on tumorigenesis |
[213] | HOPX as tumor suppressor | Human Samples | Provides insights about rare occurrence of cardiac tumors |
[120] | Wnt in cardiogenesis | Histopathology | Relevant to the progenitor-like state in cardiac myxoma |
[121] | Wnt in cardiac development and disease | Histopathology | Relevant to the progenitor-like state in cardiac myxoma |
[122] | Wnt in cardiogenesis | Histopathology | Provides insights about wnt’s impact on the cardiac proliferative potential |
[123] | Wnt and its impact on cardiac differentiation | Histopathology | Provides insights about wnt’s impact on limiting the cardiac differentiation and possible impact in the development of progenitor-like state. |
[214] | Wnt and its impact on apoptosis | Histopathology | Relevant to the progenitor-like state in cardiac myxoma |
[215] | Wnt in different tumors | Histopathology | Essential to understand its nature and impact on tumorigenesis |
[216] | Wnt in different tumors | Histopathology | Essential to understand its nature and impact on tumorigenesis |
[217] | Wnt in cardiac regeneration | Histopathology | Provides insights about wnt’s impact on the cardiac regenerative potential |
[218] | Wnt’s interaction with BMPs | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[219] | Wnt’s interaction with Isl1 and FGF | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[220] | Wnt in renewal of stem cells | Histopathology | Relevant to the progenitor-like state in cardiac myxoma |
[221] | Wnt in dedifferentiation | Human Samples | Relevant to the progenitor-like state in cardiac myxoma |
[124] | Wnt in cardiac progenitor cells | Histopathology | Relevant to the progenitor-like state in cardiac myxoma |
[125] | Wnt’s interaction with NF-κB | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[126] | FGF in heart field | Histopathology | Provides insights about early stages of cardiogenesis |
[127] | FGF in heart field | Histopathology | Provides insights about early stages of cardiogenesis |
[128] | FGF in cardiogenesis, regeneration and repair | Histopathology | Relevant to understand the limited cardiac regenerative capacity and its impact on the nature of cardiac tumors |
[129] | FGF in transitions involved in cardiac development | Histopathology | Relevant to understand the progenitor-like state in cardiac myxoma |
[130] | FGF in cardiac differentiation | Histopathology | Provides insights about the cardiac cell-type specific programming |
[131] | FGF in cardiomyocyte survival | Histopathology | Relevant to understand the homeostasis in cardiomyocytes |
[132] | FGF in stem cells | Histopathology | Relevant to understand the progenitor-like state in cardiac myxoma |
[222] | FGF and its interaction with BMPs in heart field | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[223] | FGF in postnatal cardioprotection | Histopathology | Relevant to understand the homeostasis in cardiomyocytes |
[224] | FGF in preventing pathologic cardiac remodeling | Histopathology | Relevant to understand the homeostasis in cardiomyocytes |
[225] | FGF in cardioprotection | Histopathology | Relevant to understand the homeostasis in cardiomyocytes |
[226] | FGF and its interactions with other cardiac pathways | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[227] | FGF in controlling cardiomyocyte cell cycle | Histopathology | Provides insights about the limited cardiac regenerative capacity |
[228] | FGF and its interaction with Nkx2–5 | Human Samples | Provides insights about how these interactions may influence cardiac programming |
[229] | FGF in cardiac differentiation | Human Samples | Provides insights about the cardiac cell-type specific programming |
[133] | FGF expression in cardiac myxoma | Human Samples | Relevant to understand the progenitor-like state in cardiac myxoma |
[134] | FGF in cardiac injury | Histopathology | Provides insights about the limited cardiac regenerative capacity |
[135] | BMPs in cardiac cell fate | Histopathology | Investigates BMPs in the context of cardiac cell fate |
[136] | BMPs in cardiac differentiation | Histopathology | Provides insights about the cardiac cell-type specific programming |
[137] | BMPs in cardiac differentiation | Histopathology | Provides insights about the cardiac cell-type specific programming |
[138] | BMPs and their interaction with Nkx2–5 | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[139] | BMPs and their interaction with Nkx2–5 | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[230] | BMPs in different tumors | Histopathology | Essential to understand its nature and impact on tumorigenesis |
[231] | BMPs in cardiac differentiation | Histopathology | Provides insights about the cardiac cell-type specific programming |
[232] | BMPs in different tumors | Histopathology | Essential to understand their nature and impact on tumorigenesis |
[233] | BMPs in different tumors | Human Samples | Essential to understand their nature and impact on tumorigenesis |
[234] | BMPs in mesenchymal stem cells | Human Samples | Relevant to understand the progenitor-like state in cardiac myxoma |
[235] | BMPs and their role in progenitor-like state | Histopathology | Relevant to understand the progenitor-like state in cardiac myxoma |
[236] | BMPs in tumorigenesis | Human Samples | Essential to understand their nature and impact on tumorigenesis |
[237] | BMPs in different tumors | Histopathology | Essential to understand their nature and impact on tumorigenesis |
[238] | BMPs in different tumors | Human Samples | Essential to understand their nature and impact on tumorigenesis |
[239] | BMPs in promoting tumorigenesis | Human Samples | Essential to understand their nature and impact on tumorigenesis |
[240] | BMPs in promoting tumorigenesis | Human Samples | Essential to understand their nature and impact on tumorigenesis |
[140] | Notch in lineage commitment and in cardioprotection | Histopathology | Provides insights about the cardiac cell-type specific programming and about the nature of cardiomyocytes |
[141] | Notch in cardiac regeneration | Histopathology | Provides insights about the limited cardiac regenerative potential |
[142] | Notch in development | Histopathology | Provides insights about the cardiac cell-type specific programming |
[143] | Notch in cardiogenesis | Histopathology | Relevant to understand the early stages of cardiac development |
[144] | Notch overexpression in oncogenic transformation | Histopathology | Essential to understand its nature and impact on tumorigenesis |
[145] | Notch and its interaction with BMPs in cardiogenesis | Histopathology | Provides insights about how these interactions may influence cardiac programming |
[146] | Notch signaling in cardiac development and disease | Histopathology | Provides insights about the cardiac cell-type specification in different states |
[241] | Notch in promoting stemness | Human Samples | Provides insights about the progenitor-like state in cardiac myxoma |
[242] | Notch in controlling the maintenance and commitment of cardiac stem cells | Histopathology | Provides insights about the cardiac cell-type specific programming |
[243] | Notch in stemness and tumorigenesis | Human Samples | Provides insights about the progenitor-like state in cardiac myxoma |
[244] | Notch and its interaction with Wnt pathway in regulating stemness | Human Samples | Provides insights about how these interactions may influence cardiac programming and contribute to the development of progenitor-like state in cardiac myxoma |
[148] | Clinical and molecular features of the Carney complex | Histopathology | Relevant to understand the nature of cardiac myxoma |
[149] | PRKAR1A – Carney Complex Mutations | Human Samples | Relevant to understand the nature of cardiac myxoma |
[147] | Cardiac myxoma in Carney complex | Clinical Details | Relevant to understand the nature of cardiac myxoma |
[150] | Genotype-phenotype correlation for PRKAR1A mutations | Human Samples | Relevant to understand the nature of cardiac myxoma |
[151] | Cardiac myxomas in Carney complex | Clinical Details | Relevant to understand the nature of cardiac myxoma |
[245] | Endothelial-cardiomyocyte crosstalk in cardioprotection | Histopathology | Relevant to understand the cardiac homeostasis |
[246] | Islet1 and GATA4 in cardiac regeneration | Histopathology | Essential in understanding the interactions among the proliferation and differentiation-related genes to understand the genetic landscape of cardiomyocytes |
[247] | Cell Generation and Turnover in the Human Heart | Human Samples | Relevant to understand the cardiac homeostasis |
[248] | Decline in cardiac regenerative potential | Histopathology | Provides insights about the limited cardiac regenerative potential |
[249] | Cardiac gene regulatory programs | Human Samples | Provides insights about the cardiac cell-type specific genetic programming |
[250] | Cardiogenesis and cardiac heart defects | Histopathology | Relevant to understand the significance of cardiac cell-type specific genetic programming |
[251] | Cardiac cell fate | Human Samples | Provides insights about the cardiac cell-type specific genetic programming |
[252] | Microenvironment in cardiac tumor development | Histopathology | Provides insights about the cardiac tumorigenesis |
[253] | Cardiac Stem Cell Senescence | Histopathology | Provides insights about the impact of cardiac aging on cardiac cell-type specific genetic programming |
[254] | Cardiac Stem Cell Aging | Histopathology | Provides insights about the impact of cardiac aging on cardiac cell-type specific genetic programming |
[255] | Regeneration of the aging cardiovascular system | Histopathology | Provides insights about the impact of cardiac aging on cardiac cell-type specific genetic programming |
[256] | Gene expression of cancers and its relationship to other diseases | Histopathology | Provides insights about the relationship among different genes involved in tumorigenesis landscape and how they are affected in cell types with limited regenerative capacity |
[257] | Cardiac aging | Histopathology | Provides insights about the impact of cardiac aging on cardiac cell-type specific genetic programming |
[258] | Cardiac Stem Cells in the Postnatal Heart | Histopathology | Provides insights about cardiac homeostasis |
[259] | Cardiac regenerative potential | Histopathology | Relevant to understand the limited cardiac regenerative capacity |
[260] | Tumor heterogeneity | Histopathology | Provides insights about tumorigenesis |
[261] | Tumor heterogeneity | Histopathology | Provides insights about tumorigenesis |
[262] | Tumor heterogeneity and its relation to plasticity | Histopathology | Provides insights about tumorigenesis |
[263] | Tumor heterogeneity | Histopathology | Provides insights about tumorigenesis |
[264] | Cardiogenesis in congenital heart disease | Histopathology | Provides insights about the cardiac cell-type specific genetic programming in cardiac defects |
[265] | Cardiogenesis in congenital heart disease | Histopathology | Provides insights about the cardiac cell-type specific genetic programming in cardiac defects |
[152] | Cardiac Reprogramming | Histopathology | Provides insights about the cardiac cell-type specific genetic programming |
[266] | Cardiogenesis | Histopathology | Provides insights about the cardiac cell-type specific genetic programming |
[267] | Cardiac gene-editing | Histopathology | Provides insights about the new potential therapeutic targets to tackle cardiac diseases |
[268] | Gene-editing strategies in cardiovascular cells | Histopathology | Provides insights about the new potential therapeutic targets to tackle cardiac diseases |
[269] | Gene-editing in harnessing cardiac regenerative potential | Histopathology | Provides insights about the new potential therapeutic targets to tackle cardiac diseases |
[270] | Gene-editing and cardiovascular disease | Histopathology | Provides insights about the new potential therapeutic targets to tackle cardiac diseases |
[271] | Gene-editing in cardiac research | Histopathology | Provides insights about the new potential therapeutic targets to tackle cardiac diseases |
[272] | Cardiac regeneration | Histopathology | Provides insights about the cardiac cell-type specific genetic programming in relation to cardiac regenerative potential |